https://www.selleckchem.com/pr....oducts/NVP-AUY922.ht
001) and a comparable released docetaxel concentration (P=0.43). Plasma AUCinf was 27% higher (P=0.001) and Cmax was 91% lower (P less then 0.001) for CPC634 released docetaxel. The median observed neutrophil count nadir after conventional docetaxel treatment was lower (0.50 x 109/L) compared to CPC634 (4.30 x 109/L; P less then 0.001). CONCLUSION Here, we demonstrated that CPC634 enhanced the intratumoral total docetaxel exposure compared to conventional docetaxel. The lower incidence of neutropenia during CPC634 treatment is presum